Current drug hypersensitivity challenges facing patients with cystic fibrosis. (2026)
Attributed to:
A personalised approach to manage adverse reactions to CFTR modulator therapy in patients with cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jcf.2026.01.010
PubMed Identifier: 41654434
Publication URI: http://europepmc.org/abstract/MED/41654434
Type: Journal Article/Review
Parent Publication: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
ISSN: 1569-1993